Venolife gel 2.5 + 50 + 20mg, 40 g
Expiration Date: 05/2027
Russian Pharmacy name:
Венолайф гель 2,5+50+20мг, 40 г
Edematous pain syndrome and microcirculatory-trophic disorders caused by venous insufficiency of the lower extremities (varicose veins, acute and chronic thrombophlebitis, post-thrombophlebitic syndrome, chronic lymphostasis);
- soft tissue injuries (hematomas, dislocations, sprains);
- to accelerate the granulation and epithelization of trophic ulcers in the regeneration phase (in the absence of pronounced exudation).
Locally. Apply in a thin layer to the affected area and around it 2-3 times a day, evenly spreading over the skin surface with light rubbing movements until completely absorbed. The course of treatment is 2-3 weeks. The need for further treatment is determined by the attending physician, based on the severity of the pathological process and the results of clinical tests. In case of relapse of the disease, the course of treatment can be carried out 2-3 times a year.
In case of trophic ulcers with weak exudation, before using the drug, the wound surface is cleaned of exudate and necrotic tissues, if necessary, washed with a solution of hydrogen peroxide 3%, furacilin 1: 5000 or chlorhexidine bigluconate 0.05% and dried. The gel is applied in a uniform thin layer so that the entire affected surface is covered with the preparation, and a sterile gauze bandage is applied. Dressings are changed once a day. With an open method of treatment, the drug is applied 1-2 times a day. The duration of treatment is determined by the dynamics of epithelialization.
| Gel for external use | 100 g |
| troxerutin | 2 g |
| dexpanthenol | 5 g |
| sodium heparin | 0.25 g (30,000 U) |
| excipients: phenylethyl alcohol, propylene glycol, carbomer 940 or 980, trometamol, purified water |
in an aluminum tube 30 or 40 g; in a pack of cardboard 1 tube
Hypersensitivity to the components of the drug, open infected wounds or wounds with profuse exudation.
Indications:
edematous-pain syndrome and microcirculatory-trophic disorders caused by venous insufficiency of the lower extremities (varicose veins, acute and chronic thrombophlebitis, post-thrombophlebitic syndrome, chronic lymphostasis);
soft tissue injuries (hematomas, dislocations, sprains);
to accelerate the granulation and epithelization of trophic ulcers in the regeneration phase (in the absence of pronounced exudation).
Contraindications
Hypersensitivity to the components of the drug,
open infected wounds or wounds with abundant exudation.
Application during pregnancy and lactation
VenolifeЃ is not contraindicated during pregnancy and lactation.
Method of administration and dosage
VenolifeЃ is applied in a thin layer on and around the affected area 2-3 times a day, evenly spreading over the skin surface with light rubbing movements until completely absorbed. The course of treatment is 2-3 weeks. The need for further treatment is determined by the attending physician, based on the severity of the pathological process and the results of clinical tests. In case of relapse of the disease, the course of treatment can be carried out 2-3 times a year.
In case of trophic ulcers with weak exudation, before using the drug, the wound surface is cleaned of exudate and necrotic tissues, if necessary, washed with a solution of hydrogen peroxide 3%, furacilin 1: 5000 or chlorhexidine bigluconate 0.05% and dried. The gel is applied in a uniform thin layer so that the entire affected surface is covered with the preparation, and a sterile gauze bandage is applied. Dressings are changed once a day. With an open method of treatment, the drug is applied 12 times a day. The duration of treatment is determined by the dynamics of epithelialization.
Side effect
Local manifestations of allergic reactions (skin rash, itching) are possible.
Special instructions
VenolifeЃ is not intended for use in ophthalmology, for intravaginal and rectal administration.